Xiaoling Li

Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study

Qing Zhou, Chong‐Rui Xu, Ying Cheng et al. · Cancer Cell · 2021 · 220 citations

Advanced Nsclc, Novel Therapy, Multicenter Phase 3 +9

Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2

Yongzhen Mo, Yumin Wang, Shuai Zhang et al. · Molecular Cancer · 2021 · 165 citations · Full text

Effect of rainwater harvesting with ridge and furrow on yield of potato in semiarid areas

Yuan Tian, Derong Su, Feng‐Min Li et al. · Field Crops Research · 2003 · 162 citations · Full text

Irrigation Management, Engineering, Semiarid Areas +10

Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)

Zhijie Wang, Lin Wu, Baolan Li et al. · Journal of Clinical Oncology · 2022 · 161 citations · Full text

Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation

Zeda Zhang, Chuanli Zhou, Xiaoling Li et al. · Cancer Cell · 2020 · 158 citations · Full text

Genetics, Chromatin Dysregulation, Epigenetics +16